Elsevier

Journal of Proteomics

Volume 75, Issue 11, 18 June 2012, Pages 3098-3112
Journal of Proteomics

Review
Recent advances in sialic acid-focused glycomics

https://doi.org/10.1016/j.jprot.2012.03.050Get rights and content

Abstract

Recent emergences of glycobiology, glycotechnology and glycomics have been clarifying enormous roles of carbohydrates in biological recognition systems. For example, cell surface carbohydrates existing as glycoconjugates (glycolipids, glycoproteins and proteoglycans) play crucial roles in cell–cell communication, cell proliferation and differentiation, tumor metastasis, inflammatory response or viral infection. In particular, sialic acids (SAs) existing as terminal residues in carbohydrate chains on cell surface are involved in signal recognition and adhesion to ligands, antibodies, enzymes and microbes. In addition, plasma free SAs and sialoglycans have shown great potential for disease biomarker discovery. Therefore, the development of efficient analytical methods for structural and functional studies of SAs and sialylglycans are very important and highly demanded. The problems of SAs and sialylglycans analysis are vanishingly small sample amount, complicated and unstable structures, and complex mixtures. Nevertheless, in the past decade, mass spectrometry in combination with chemical derivatization and modern separation methodologies has become a powerful and versatile technique for structural analysis of SAs and sialylglycans. This review summarizes these recent advances in glycomic studies on SAs and sialylglycans. Specially, derivatization and capturing of SAs and sialylglycans combined with mass spectrometry analysis are highlighted.

Graphical abstract

Highlights

► Sialic acids existing on cell surface play important roles in a biological system. ► Plasma sialic acids show great potential for disease biomarker discovery. ► Modification of sialic acids enhances their stability in mass spectrometry analysis. ► Modification of sialic acids improves their ionization in mass spectrometry analysis.

Introduction

Glycosylation is a common post-translational modification that plays important roles in both physiological and pathological pathways. The glycan moieties of extracellular glycoproteins may stabilize the conformation of proteins and confer proteolytic resistance and influence protein turnover, and are involved in receptor–ligand interactions, cell–cell signaling, and adhesion, however, molecular mechanisms in many instances are still unknown [1]. Detailed knowledge of protein glycosylation at the proteomics level involving structural information of both the glycan microheterogeneity and the backbone peptide sequence, known as glycoproteomics, will facilitate mechanism investigation of glycoprotein and is of growing importance in postgenomic science and clinical research [2]. In addition, abnormal protein glycosylation is highly involved in disease development [3]. Glycoproteomic studying uncovers new clinical glycoprotein biomarkers, which can be used for both disease diagnosis and monitoring and evaluating therapeutic efficiency, and even for personal medicine purpose. On the other hand, there has been a rapid increase in the number of glycoproteins approved as biopharmaceuticals [4]. Glycan analysis is an important quality parameter of biopharmaceuticals with regard to drug stability, clinical activity, and immunogenicity [5], [6].

Sialic acids (SAs), a family of 9-carbon containing acidic monosaccharides, often terminate the glycan structures of cell surface and secreted glycoconjugates such as glycoproteins and glycolipids. They are found on both N- and O-linked glycans, being attached to either galactose (Gal), or N-acetylgalactosamine (GalNAc) units via α2,3- or α2,6-linkages, or to SA via α2,8- or α2,9-linkages, whose syntheses are catalyzed by specific enzymes [7]. In addition, various substituents present on carbon 4, 5, 7, 8 and 9 positions generate more than 50 SA species (Fig. 1). SAs play crucial roles in cell surface interactions [8], protect cells from membrane proteolysis [9], help in cell adhesion and have been shown to determine the half-life of glycoproteins in blood [10]. It has been demonstrated previously that cancers and cancer staging may be associated with a significant overrepresentation of SAs on the surface glycoproteins of cancer cells compared with normal cells [11], [12], [13], [14], [15], [16], [17], [18]. Also, it is well known that the amount of free SAs and lipid- and protein-bound SAs are elevated in plasma from cancer patients compared with healthy individuals [19], [20], [21], [22]. In addition, glycosylation microheterogeneity in the form of different branching patterns (where the number of sialic acid moieties reflects the glycan branching structure) is linked with acute phase condition and chronic disease [23], [24], possibly indicating that SAs or SA-containing glycoproteins/peptides could be good biomarker candidates for cancer diseases. Therefore, the ability to detect and monitor changes in the sialylated glycans could be an important aid in the diagnosis of cancer at an earlier stage, thus improving the patient's prognosis. Both glycomics and glycoproteomics data defined a significant change in sialylation as the most prominent feature associated with serum acute phase glycoproteins from mice bearing tumors [25].

Mass spectrometry (MS) has become a central tool for monitoring, identifying and characterizing biomolecules in bioscience. With an increasing ability to correctly characterize miniscule quantities and more complex mixtures of proteins and peptides, MS has been quickly becoming a key tool in the glycomics recently [26]. It provides many advantages over traditional analytical methods, such as low sample consumption and high sensitivity. Particularly, the developments of matrix-assisted laser desorption/ionization (MALDI) and electrospray ionization (ESI) mass spectrometry have greatly accelerated the use of MS-based technology in structural analysis of carbohydrates [27]. MALDI MS in conjunction with enzymatic digests and post source decay has been widely used for identification and structural determination of the glycans. ESI and collision-induced dissociation (CID) has been proved to be powerful and versatile techniques to obtain detailed structural and linkage information on complex carbohydrates, especially with the MSn capability of the ion trap. The gain in measurement sensitivity achieved with glycans during the past decade has been highly significant. However, it should be noted that SA-containing acidic oligosaccharides had not yet fully benefited from the usefulness of mass spectrometry in the early stage. This is mostly due to the instability of the α-glycosidic bond between SA and the adjacent sugar residue under general conditions for ionization/detection processes during mass measurement, giving rise to several inevitable difficulties in the analysis. It has been well documented that various sialylated oligosaccharides, when analyzed by mass spectrometry in either positive or negative-ion modes, lose SAs as a result of the presence of the free carboxyl group. In addition, oligosaccharides containing multiple SA residues usually give complicated mass spectra resulting from mixtures of cation adducts when analyzed in positive-ion mode. It therefore seems likely that structural heterogeneity due to the partial loss of SA residues has often been reduced by the complete removal of terminal SAs from the target oligosaccharides on treatment with some acidic solutions [28]. Therefore, the development of simple and versatile method for avoiding the risk of desialylation has been explored extensively. With the goals of addressing these issues in measurements of acidic oligosaccharides in mass spectrometry, as well as of enhancing the sensitivity and resolution, several approaches have been employed so far. One approach is chemical modifications of sialylated glycans, which stabilizes sialic acids and improve the ionization efficiency of the glycans for MS analysis. On the other hand, the inherent ionization bias of MALDI MS may lead to preferential detection of unmodified peptides and partial or complete suppression of glycopeptides. In such cases, a separation step for removal of peptides and enrichment of glycopeptides is needed prior to the MALDI MS detection. Various methods for enrichment and separation of SA-containing glycopeptides and SAs have been developed including using lectins. Herein, we summarize recent advances in glycomic analysis that focuses on SAs and sialylglycans, the most important human glycoforms. Specially, SA derivatization and SA capturing combined with mass spectrometry analysis are highlighted.

Section snippets

Derivatization of sialylglycans for their mass spectrometry analysis

The labile nature of SA poses a challenge for MS characterization. In-source and post-source losses of SA often lead to inaccurate representation of the degree of sialylation. Sialylated glycans usually decompose by loss of SA when ionized by MALDI MS as the result of the labile carboxylic proton. In addition, ionic signal suppression is often a major issue in the analysis of sialylated glycans by MS, particularly due to the presence of a carboxyl group at the anomeric carbon, which is usually

Capturing sialylglycans for their mass spectrometry analysis

Glycoprofiling of glycoproteins, glycopeptides and glycans is conveniently achieved by MALDI MS and MS/MS due to the high sensitivity, speed and robustness of this technique [51], [52]. However, the inherent ionization bias of MALDI MS may lead to preferential detection of unmodified peptides and partial or complete suppression of glycopeptides. In such cases, a separation step for removal of peptides and enrichment of glycopeptides is needed prior to the MALDI MS detection [53]. Various

Mass spectrometry analysis of sialylglycans

Mass spectrometry has become the practical analytical tool in glycomics and glycoproteomics. Two types of soft ionization techniques, MALDI and ESI, are generally used for the analysis of glycans. Four mass analyzer systems, time-of-flight (TOF), ion trap (IT), Fourier transform ion cyclotron resonance (FT-ICR), and Orbitrap are used in mass spectrometry for analysis of glycans. In addition, tandem MS methods such as TOF/TOF, QIT-TOF, LTQ FT-ICR, and LTQ-Orbitrap are used to analyze the

Conclusion

SAs are terminal residues in carbohydrate chains on cell surface and are involved in both physiological and pathological pathways. In addition, plasma free SA and sialoglycans have shown great potential for disease biomarker discovery. During the past decade, the developments of MALDI and ESI mass spectrometry have greatly accelerated the use of MS-based technology in structural analysis of sialoglycans. Particularly, simple and versatile method for avoiding the risk of desialylation during MS

Acknowledgements

This work was partially supported by grants from The National Natural Science Foundation of China (30700987 and 81171945, H. Nie and Y. Li). This work was also partially supported by grants from the NIH grant (1R01HL102604-03, X.-L. Sun), the Ohio Research Scholar Program grant (X.-L. Sun) and NSF MRI grant (CHE-1126384, X.-L. Sun).

References (110)

  • D.J. Harvey

    Matrix-assisted laser de-sorption/ionization mass spectrometry of carbohydrates and glycoconjugates

    Int J Mass Spectrom

    (2003)
  • M.R. Larsen et al.

    Characterization of gel-separated glycoproteins using two-step proteolytic digestion combined with sequential microcolumns and mass spectrometry

    Mol Cell Proteomics

    (2005)
  • M.R. Larsen et al.

    Exploring the sialiome using titanium dioxide chromatography and mass spectrometry

    Mol Cell Proteomics

    (2007)
  • C.D. Calvano et al.

    Assessment of lectin and HILIC based enrichment protocols for characterization of serum glycoproteins by mass spectrometry

    J Proteomics

    (2008)
  • Z. Yang et al.

    Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affinity column

    J Chromatogr A

    (2004)
  • R.D. Cummings et al.

    Fractionation of asparagine-linked oligosaccharides by serial lectin-Agarose affinity chromatography. A rapid, sensitive, and specific technique

    J Biol Chem

    (1982)
  • M. Kurogochi et al.

    Sialic acid-focused quantitative mouse serum glycoproteomics by multiple reaction monitoring assay

    Mol Cell Proteomics

    (2010)
  • M. Guillard et al.

    Automated measurement of permethylated serum N-glycans by MALDI-linear ion trap mass spectrometry

    Carbohydr Res

    (2009)
  • D.J. Harvey

    Fragmentation of negative ions from carbohydrates: part 1. Use of nitrate and other anionic adducts for the production of negative ion electrospray spectra from N-linked carbohydrates

    J Am Soc Mass Spectrom

    (2005)
  • S.I. Snovida et al.

    On the use of DHB/aniline and DHB/N, N-dimethylaniline matrices for improved detection of carbohydrates: automated identification of oligosaccharides and quantitative analysis of sialylated glycans by MALDI-TOF mass spectrometry

    J Am Soc Mass Spectrom

    (2008)
  • I. Ciucanu et al.

    A simple and rapid method for the permethylation of carbohydrates

    Carbohydr Res

    (1984)
  • P.F. Daniel

    Separation of benzoylated oligosaccharides by reversed-phase high-pressure liquid chromatography: application to high-mannose type oligosaccharides

    Methods Enzymol

    (1987)
  • A. Varki

    Biological roles of oligosaccharides: all of the theories are correct

    Glycobiology

    (1993)
  • R. Aebersold et al.

    Mass spectrometry-based proteomics

    Nature

    (2003)
  • D.H. Dube et al.

    Glycans in cancer and inflammation—potential for therapeutics and diagnostics

    Nat Rev Drug Discov

    (2005)
  • G. Walsh

    Biopharmaceutical benchmarks

    Nat Biotechnol

    (2003)
  • N. Casadevall et al.

    Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin

    N Engl J Med

    (2002)
  • M. Butler

    Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals

    Appl Microbiol Biotechnol

    (2005)
  • X. Chen et al.

    Advances in the biology and chemistry of sialic acids

    ACS Chem Biol

    (2010)
  • P. Gorog et al.

    Sialic acid moieties on surface glycoproteins protect endothelial cells from proteolytic damage

    J Pathol

    (1985)
  • C. Feijoo-Carnero et al.

    Clinical significance of preoperative serum sialic acid levels in colorectal cancer: utility in the detection of patients at high risk of tumor recurrence

    Int J Biol Markers

    (2004)
  • S.S. Gokmen et al.

    Relationship between serum sialic acids, sialic acid-rich inflammation-sensitive proteins and cell damage in patients with acute myocardial infarction

    Clin Chem Lab Med

    (2006)
  • M. Kaur et al.

    Diagnostic prognostic value of serum glycoproteins (sialic acid and hexosamines) in breast cancer

    Clin Chem

    (2005)
  • T. Miyagi et al.

    Aberrant expression of sialidase in cancer

    Trends Glycosci Glycotechnol

    (2004)
  • T.F. Scanlin et al.

    Terminal glycosylation and disease: Influence on cancer and cystic fibrosis

    Glycoconj J

    (2000)
  • A.V. Thougaard et al.

    Correlation between α1-acid glycoprotein and total sialic acid in serum from dogs with tumours

    Zentralbl Veterinarmed A

    (1999)
  • P.H. Wang et al.

    Different enzyme activities of sialyltransferases in gynecological cancer cell lines

    Eur J Gynaecol Oncol

    (2002)
  • M. Basoglu et al.

    Levels of soluble intercellular adhesion molecule-1 and total sialic acid in serum of patients with colorectal cancer

    J Surg Oncol

    (2003)
  • K.B. Rajpura et al.

    Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer

    J Oral Pathol Med

    (2005)
  • J. Romppanen et al.

    Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer

    Anticancer Res

    (2002)
  • C. Uslu et al.

    Serum free and bound sialic acid and α-1-acid glycoprotein in patients with laryngeal cancer

    Ann Clin Lab Sci

    (2003)
  • S. Lijima et al.

    Changes of α1-acid glycoprotein microheterogeneity in acute inflammation stages analyzed by isoelectric focusing using serum obtained postoperatively

    Electrophoresis

    (2000)
  • S.Y. Lin et al.

    Precise mapping of increased sialylation pattern and the expression of acute phaseproteins accompanying murine tumor progression in BALB/c mouse by integrated sera proteomics and glycomics

    J Proteome Res

    (2008)
  • J. Zaia

    Mass spectrometry and glycomics

    OMICS

    (2010)
  • J. Zaia

    Mass spectrometry of oligosaccharides

    Mass Spectrom Rev

    (2004)
  • J.J. Pitt et al.

    Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of sialylated glycopeptides and proteins using 2,6-dihydroxyacetophenone as a matrix

    Rapid Commun Mass Spectrom

    (1996)
  • P.B. O'Connor et al.

    A high pressure matrix-assisted laser desorption/ionization Fourier transform mass spectrometry ion source for thermal stabilization of labile biomolecules

    Rapid Commun Mass Spectrom

    (2001)
  • A.K. Powell et al.

    Stabilization of sialic acids in N-linked oligosaccharides and gangliosides for analysis by positive ion matrix-assisted laser desorption/ionization mass spectrometry

    Rapid Commun Mass Spectrom

    (1996)
  • X. Liu et al.

    “One-pot” methylation in glycomics application: esterification of sialic acids and permanent charge construction

    Anal Chem

    (2007)
  • Y. Miura et al.

    Rapid and simple solid-phase esterification of sialic acid residues for quantitative glycomics by mass spectrometry

    Chem Eur J

    (2007)
  • Cited by (60)

    • Recent advances and trends in sample preparation and chemical modification for glycan analysis

      2022, Journal of Pharmaceutical and Biomedical Analysis
      Citation Excerpt :

      The remaining reagents used in glycan release and chemical modification steps are often problematic for the following workflow and is one of bottlenecks for the analysis of chemically modified released glycans. To achieve selective enrichment for focused glycomics (e.g. sialic-acid-focused glycomics), an in-depth understanding of unknown functions or identification of disease-specific glycobiomarkers is required [171]. This section summarizes the purification methods for chemically modified glycans and focuses on the recent rapid and facile sample purification methods for glycan derivatives to facilitate glycomics research.

    • Glycan Imaging Mass Spectrometry: Progress in Developing Clinical Diagnostic Assays for Tissues, Biofluids, and Cells

      2021, Clinics in Laboratory Medicine
      Citation Excerpt :

      Using Endo F3 and PNGase F in a 1:10 ratio can free both core and terminally fucosylated N-glycan isomers in a single tissue analysis. Distinguishing the isomeric linkages of α-2,3 versus α-2,6 sialic acid residues on N-glycans is further complicated by the lability of sialic acid residues during MALDI ionization, as well as by the fact that the negative charge of sialic acids typically forms salt adducts with additional sodium ions, reducing sensitivity of detection.68,69 To overcome these challenges, an on-tissue chemical amidation approach has been developed that stabilizes sialic acid residues before preparation for MALDI-IMS.53

    • Aniline derivative/DHB/alkali metal matrices for reflectron mode MALDI-TOF and TOF/TOF MS analysis of unmodified sialylated oligosaccharides and glycopeptides

      2019, International Journal of Mass Spectrometry
      Citation Excerpt :

      The high-sensitivity and homogeneous properties of the aniline derivative/DHB matrix systems may have a major advantage for automated analysis of a large number of samples with a pre-spotted target plate. There have been few reports on methods that can avoid fragmentation of sialic acid residues without modification in reflectron mode [3,4]; however, loss of the sialic acid residue can be prevented by controlling the number of adduct metal ions even in reflectron mode [3]. Addition of a sodium source is the simplest way to simplify the adduct ion pattern on the sialic acid residue during ionization [6,7].

    • Label-free cytosensing of cancer cells based on the interaction between protein and an electron-transfer carbohydrate-mimetic peptide

      2018, Analytica Chimica Acta
      Citation Excerpt :

      For example, Sialyl Lewis X on the surface of leukocytes is conjugated with E-and P-selectins that are expressed in thrombocytes and vascular endothelial cells [5]. Most glycoproteins in human serum have carbohydrate chains that consist of sialic acid and galactose-acetylglucosamine residue [6]. When function deterioration and aging of glycoproteins occurs, sialic acid residue is removed from the protein.

    View all citing articles on Scopus
    View full text